ReP USP - Resultado da busca

Trabalho de evento-resumo
Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH) (2017)
Calado, Rodrigo Tocantins
Source: Abstracts. Conference titles: International Conference on Complement Therapeutics. Unidade: FMRP
Subjects: ANEMIA, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALADO, Rodrigo Tocantins. Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH). 2017, Anais.. Crete: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2017. . Acesso em: 18 nov. 2024.
APA
Calado, R. T. (2017). Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH). In Abstracts. Crete: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Calado RT. Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH). Abstracts. 2017 ;[citado 2024 nov. 18 ]
Vancouver
Calado RT. Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH). Abstracts. 2017 ;[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models (2017)
Machado Neto, João Agostinho ; Ribeiro, Renata Scopim; Coelho-Silva, Juan Luiz; Eide, Christopher A.; Fenerich, Bruna Alves; Fernandes, Jaqueline Cristina; Alves, Ana Paula Nunes Rodrigues; Scheucher, Priscila Santos; Tognon, Cristina E.; Figueiredo-Pontes, Lorena Lobo; Druker, Brian J.; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Blood. Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH). Unidades: ICB, FMRP
Subjects: DOENÇAS HEMATOLÓGICAS, NEOPLASIAS, METFORMINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/4222. Acesso em: 18 nov. 2024. , 2017
APA
Machado Neto, J. A., Ribeiro, R. S., Coelho-Silva, J. L., Eide, C. A., Fenerich, B. A., Fernandes, J. C., et al. (2017). Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/4222
NLM
Machado Neto JA, Ribeiro RS, Coelho-Silva JL, Eide CA, Fenerich BA, Fernandes JC, Alves APNR, Scheucher PS, Tognon CE, Figueiredo-Pontes LL, Druker BJ, Rego EM, Traina F. Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/4222
Vancouver
Machado Neto JA, Ribeiro RS, Coelho-Silva JL, Eide CA, Fenerich BA, Fernandes JC, Alves APNR, Scheucher PS, Tognon CE, Figueiredo-Pontes LL, Druker BJ, Rego EM, Traina F. Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/4222
Trabalho de evento-resumo periodico
Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells (2017)
Machado Neto, João Agostinho ; Coelho-Silva, Juan Luiz; Lucena-Araujo, Antonio R.; Scheucher, Priscila Santos; Melo, Raul Antônio Morais; Bittencourt, Rosane; Pasquini, Ricardo; Pagnano, Katia B. B; Fagundes, Evandro Maranhão; Chauffaille, Maria de Lourdes; Chiattone, Carlos; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Blood. Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH). Unidades: ICB, FMRP
Subjects: LEUCEMIA, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/2514. Acesso em: 18 nov. 2024. , 2017
APA
Machado Neto, J. A., Coelho-Silva, J. L., Lucena-Araujo, A. R., Scheucher, P. S., Melo, R. A. M., Bittencourt, R., et al. (2017). Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/2514
NLM
Machado Neto JA, Coelho-Silva JL, Lucena-Araujo AR, Scheucher PS, Melo RAM, Bittencourt R, Pasquini R, Pagnano KBB, Fagundes EM, Chauffaille M de L, Chiattone C, Rego EM, Traina F. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/2514
Vancouver
Machado Neto JA, Coelho-Silva JL, Lucena-Araujo AR, Scheucher PS, Melo RAM, Bittencourt R, Pasquini R, Pagnano KBB, Fagundes EM, Chauffaille M de L, Chiattone C, Rego EM, Traina F. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/2514
Artigo de periodico
Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome (2017)
Silva, Fernanda Borges da; Machado Neto, João Agostinho ; Bertini, Virginia Helena Leira Lipoli; Velloso, Elvira Deolinda Rodrigues Pereira; Ratis, Cristina Alonso; Calado, Rodrigo Tocantins; Simões, Belinda Pinto; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Journal of Clinical Pathology. Unidades: FM, FMRP
Subjects: CITOGENÉTICA, ANORMALIDADES CROMOSSÔMICAS, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Fernanda Borges da et al. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome. Journal of Clinical Pathology, v. 70, n. 5, p. 435-442, 2017Tradução . . Disponível em: https://doi.org/10.1136/jclinpath-2016-204023. Acesso em: 18 nov. 2024.
APA
Silva, F. B. da, Machado Neto, J. A., Bertini, V. H. L. L., Velloso, E. D. R. P., Ratis, C. A., Calado, R. T., et al. (2017). Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome. Journal of Clinical Pathology, 70( 5), 435-442. doi:10.1136/jclinpath-2016-204023
NLM
Silva FB da, Machado Neto JA, Bertini VHLL, Velloso EDRP, Ratis CA, Calado RT, Simões BP, Rego EM, Traina F. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome [Internet]. Journal of Clinical Pathology. 2017 ; 70( 5): 435-442.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1136/jclinpath-2016-204023
Vancouver
Silva FB da, Machado Neto JA, Bertini VHLL, Velloso EDRP, Ratis CA, Calado RT, Simões BP, Rego EM, Traina F. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome [Internet]. Journal of Clinical Pathology. 2017 ; 70( 5): 435-442.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1136/jclinpath-2016-204023
Trabalho de evento-resumo periodico
DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients (2017)
Ribeiro, Renata Scopim; Machado Neto, João Agostinho ; Campos, Paula De Melo; Eide, Christopher A.; Savage, Samantha L.; Lorand-Metze, Irene; Tognon, Cristina E.; Costa, Fernando Ferreira; Druker, Brian J.; Saad, Sara Teresinha Olalla; Traina, Fabiola
Source: Blood. Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH). Unidades: ICB, FMRP
Subjects: NEOPLASIAS, DOENÇAS HEMATOLÓGICAS, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Renata Scopim et al. DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/3969. Acesso em: 18 nov. 2024. , 2017
APA
Ribeiro, R. S., Machado Neto, J. A., Campos, P. D. M., Eide, C. A., Savage, S. L., Lorand-Metze, I., et al. (2017). DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/3969
NLM
Ribeiro RS, Machado Neto JA, Campos PDM, Eide CA, Savage SL, Lorand-Metze I, Tognon CE, Costa FF, Druker BJ, Saad STO, Traina F. DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3969
Vancouver
Ribeiro RS, Machado Neto JA, Campos PDM, Eide CA, Savage SL, Lorand-Metze I, Tognon CE, Costa FF, Druker BJ, Saad STO, Traina F. DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3969
Trabalho de evento-resumo periodico
IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia (2017)
Coelho-Silva, Juan Luiz; Machado Neto, João Agostinho ; Fernandes, Jaqueline Cristina; Lima, Ana Silvia G. de; Scheucher, Priscila Santos; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Blood. Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH). Unidades: ICB, FMRP
Subjects: LEUCEMIA, DOENÇAS HEMATOLÓGICAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO-SILVA, Juan Luiz et al. IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/3966. Acesso em: 18 nov. 2024. , 2017
APA
Coelho-Silva, J. L., Machado Neto, J. A., Fernandes, J. C., Lima, A. S. G. de, Scheucher, P. S., Rego, E. M., & Traina, F. (2017). IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/3966
NLM
Coelho-Silva JL, Machado Neto JA, Fernandes JC, Lima ASG de, Scheucher PS, Rego EM, Traina F. IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3966
Vancouver
Coelho-Silva JL, Machado Neto JA, Fernandes JC, Lima ASG de, Scheucher PS, Rego EM, Traina F. IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3966
Trabalho de evento-resumo periodico
The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms (2017)
Fenerich, Bruna Alves; Machado Neto, João Agostinho ; Alves, Ana Paula Nunes Rodrigues; Campos, Paula de Melo; Fernandes, Jaqueline Cristina; Coelho-Silva, Juan Luiz; Ribeiro, Renata Scopim; Silva,Fernanda B. da; Scheucher, Priscila Santos; Figueiredo-Pontes, Lorena Lobo; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Blood. Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH). Unidades: ICB, FMRP
Subjects: QUIMIOTERAPIA, NEOPLASIAS, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FENERICH, Bruna Alves et al. The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/1253. Acesso em: 18 nov. 2024. , 2017
APA
Fenerich, B. A., Machado Neto, J. A., Alves, A. P. N. R., Campos, P. de M., Fernandes, J. C., Coelho-Silva, J. L., et al. (2017). The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/1253
NLM
Fenerich BA, Machado Neto JA, Alves APNR, Campos P de M, Fernandes JC, Coelho-Silva JL, Ribeiro RS, Silva FB da, Scheucher PS, Figueiredo-Pontes LL, Rego EM, Traina F. The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/1253
Vancouver
Fenerich BA, Machado Neto JA, Alves APNR, Campos P de M, Fernandes JC, Coelho-Silva JL, Ribeiro RS, Silva FB da, Scheucher PS, Figueiredo-Pontes LL, Rego EM, Traina F. The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms [Internet]. Blood. 2017 ; 130[citado 2024 nov. 18 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/1253
Artigo de periodico
Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors (2015)
Reis-Alves, Suiellen C.; Traina, Fabíola; Metze, Konradin; Lorand-Metze, Irene
Source: Diabetology & Metabolic Syndrome. Unidade: FMRP
Subjects: DOENÇAS HEMATOLÓGICAS, IMUNOFENOTIPAGEM, CITOMETRIA DE FLUXO, MEDULA ÓSSEA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS-ALVES, Suiellen C. et al. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors. Diabetology & Metabolic Syndrome, v. 10, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13000-015-0259-3. Acesso em: 18 nov. 2024.
APA
Reis-Alves, S. C., Traina, F., Metze, K., & Lorand-Metze, I. (2015). Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors. Diabetology & Metabolic Syndrome, 10. doi:10.1186/s13000-015-0259-3
NLM
Reis-Alves SC, Traina F, Metze K, Lorand-Metze I. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors [Internet]. Diabetology & Metabolic Syndrome. 2015 ; 10[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s13000-015-0259-3
Vancouver
Reis-Alves SC, Traina F, Metze K, Lorand-Metze I. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors [Internet]. Diabetology & Metabolic Syndrome. 2015 ; 10[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s13000-015-0259-3
Artigo de periodico
Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia (2015)
Clé, Diego V.; Santana-Lemos, Barbara; Tellechea, Maria Florencia; Prata, Karen L.; Orellana, Maristela D.; Covas, Dimas Tadeu; Calado, Rodrigo Tocantins
Source: Cytotherapy. Unidade: FMRP
Subjects: ANEMIA, IMUNOSSUPRESSÃO, MEDULA ÓSSEA, CÉLULAS-TRONCO, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CLÉ, Diego V. et al. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia. Cytotherapy, v. 17, n. 12, p. 1696-1705, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jcyt.2015.09.006. Acesso em: 18 nov. 2024.
APA
Clé, D. V., Santana-Lemos, B., Tellechea, M. F., Prata, K. L., Orellana, M. D., Covas, D. T., & Calado, R. T. (2015). Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia. Cytotherapy, 17( 12), 1696-1705. doi:10.1016/j.jcyt.2015.09.006
NLM
Clé DV, Santana-Lemos B, Tellechea MF, Prata KL, Orellana MD, Covas DT, Calado RT. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia [Internet]. Cytotherapy. 2015 ; 17( 12): 1696-1705.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.jcyt.2015.09.006
Vancouver
Clé DV, Santana-Lemos B, Tellechea MF, Prata KL, Orellana MD, Covas DT, Calado RT. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia [Internet]. Cytotherapy. 2015 ; 17( 12): 1696-1705.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.jcyt.2015.09.006
Artigo de periodico
Elevated hypercoagulability markers in hemoglobin SC disease (2015)
Colella, Marina P.; Paula, Erich V. de; Machado Neto, João Agostinho ; Conran, Nicola; Annichino-Bizzacchi, Joyce M.; Costa, Fernado F.; Olalla Saad, Sara T.; Traina, Fabiola
Source: Haematologica. Unidade: FMRP
Subjects: HEMOGLOBINAS, ANEMIA FALCIFORME, DOENÇAS HEMATOLÓGICAS, TRANSTORNOS DA COAGULAÇÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLELLA, Marina P. et al. Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica, v. 100, n. 4, p. 466-471, 2015Tradução . . Disponível em: https://doi.org/10.3324/haematol.2014.114587. Acesso em: 18 nov. 2024.
APA
Colella, M. P., Paula, E. V. de, Machado Neto, J. A., Conran, N., Annichino-Bizzacchi, J. M., Costa, F. F., et al. (2015). Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica, 100( 4), 466-471. doi:10.3324/haematol.2014.114587
NLM
Colella MP, Paula EV de, Machado Neto JA, Conran N, Annichino-Bizzacchi JM, Costa FF, Olalla Saad ST, Traina F. Elevated hypercoagulability markers in hemoglobin SC disease [Internet]. Haematologica. 2015 ; 100( 4): 466-471.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3324/haematol.2014.114587
Vancouver
Colella MP, Paula EV de, Machado Neto JA, Conran N, Annichino-Bizzacchi JM, Costa FF, Olalla Saad ST, Traina F. Elevated hypercoagulability markers in hemoglobin SC disease [Internet]. Haematologica. 2015 ; 100( 4): 466-471.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3324/haematol.2014.114587
Artigo de periodico
Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk (2015)
Spina, M.; Nagy, Z.; Ribera, J. M.; Federico, M.; Aurer, I.; Jordan, K.; Borsaru, G.; Pristupa, A. S.; Bosi, A.; Grosicki, S.; Glushko, N. L.; Ristic, D.; Jakucs, J.; Montesinos, P.; Mayer, J.; Rego, Eduardo Magalhães; Baldini, S.; Scartoni, S.; Capriati, A.; Maggi, C. A.; Simonelli, C.
Source: Annals of Oncology. Unidade: FMRP
Subjects: NEOPLASIAS, HEMATOLOGIA, RIM, ÁCIDO ÚRICO, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPINA, M. et al. Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Annals of Oncology, v. 26, n. 10, p. 2155-2161, 2015Tradução . . Disponível em: https://doi.org/10.1093/annonc/mdv317. Acesso em: 18 nov. 2024.
APA
Spina, M., Nagy, Z., Ribera, J. M., Federico, M., Aurer, I., Jordan, K., et al. (2015). Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Annals of Oncology, 26( 10), 2155-2161. doi:10.1093/annonc/mdv317
NLM
Spina M, Nagy Z, Ribera JM, Federico M, Aurer I, Jordan K, Borsaru G, Pristupa AS, Bosi A, Grosicki S, Glushko NL, Ristic D, Jakucs J, Montesinos P, Mayer J, Rego EM, Baldini S, Scartoni S, Capriati A, Maggi CA, Simonelli C. Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk [Internet]. Annals of Oncology. 2015 ; 26( 10): 2155-2161.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/annonc/mdv317
Vancouver
Spina M, Nagy Z, Ribera JM, Federico M, Aurer I, Jordan K, Borsaru G, Pristupa AS, Bosi A, Grosicki S, Glushko NL, Ristic D, Jakucs J, Montesinos P, Mayer J, Rego EM, Baldini S, Scartoni S, Capriati A, Maggi CA, Simonelli C. Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk [Internet]. Annals of Oncology. 2015 ; 26( 10): 2155-2161.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/annonc/mdv317
Trabalho de evento-resumo
Padronização de diferentes metodologias para investigação molecular da presença da mutação JAK2V616F em pacientes com neoplasia mieloide na FMRP USP (2014)
Fenerich, B. A.; Lima, A. S. G.; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Resumos da Faculdade de Medicina de Ribeirão Preto: 1ª etapa. Conference titles: Simpósio Internacional de Iniciação Científica da USP (SIICUSP). Unidade: FMRP
Subjects: MUTAÇÃO GENÉTICA, NEOPLASIAS, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FENERICH, B. A. et al. Padronização de diferentes metodologias para investigação molecular da presença da mutação JAK2V616F em pacientes com neoplasia mieloide na FMRP USP. 2014, Anais.. Ribeirão Preto: FMRP-USP, 2014. . Acesso em: 18 nov. 2024.
APA
Fenerich, B. A., Lima, A. S. G., Rego, E. M., & Traina, F. (2014). Padronização de diferentes metodologias para investigação molecular da presença da mutação JAK2V616F em pacientes com neoplasia mieloide na FMRP USP. In Resumos da Faculdade de Medicina de Ribeirão Preto: 1ª etapa. Ribeirão Preto: FMRP-USP.
NLM
Fenerich BA, Lima ASG, Rego EM, Traina F. Padronização de diferentes metodologias para investigação molecular da presença da mutação JAK2V616F em pacientes com neoplasia mieloide na FMRP USP. Resumos da Faculdade de Medicina de Ribeirão Preto: 1ª etapa. 2014 ;[citado 2024 nov. 18 ]
Vancouver
Fenerich BA, Lima ASG, Rego EM, Traina F. Padronização de diferentes metodologias para investigação molecular da presença da mutação JAK2V616F em pacientes com neoplasia mieloide na FMRP USP. Resumos da Faculdade de Medicina de Ribeirão Preto: 1ª etapa. 2014 ;[citado 2024 nov. 18 ]
Artigo de periodico
Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion (2014)
Roversi, Fernanda Marconi; Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Longhini, Ana Leda F.; Duarte, Adriana Silva Santos; Baratti, Mariana O.; Palodetto, Bruna; Corrocher, Flávia Adolfo; Pericole, Fernando V.; Campos, Paula de Melo; Favaro, Patricia; Traina, Fabíola; Saad, Sara Teresinha Olalla
Source: Stem Cells and Development. Unidade: FMRP
Subjects: DOENÇAS HEMATOLÓGICAS, HEMATOPOESE, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVERSI, Fernanda Marconi et al. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion. Stem Cells and Development, v. 23, n. 10, p. 1109-1120, 2014Tradução . . Disponível em: https://doi.org/10.1089/scd.2013.0441. Acesso em: 18 nov. 2024.
APA
Roversi, F. M., Lopes, M. R., Machado Neto, J. A., Longhini, A. L. F., Duarte, A. S. S., Baratti, M. O., et al. (2014). Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion. Stem Cells and Development, 23( 10), 1109-1120. doi:10.1089/scd.2013.0441
NLM
Roversi FM, Lopes MR, Machado Neto JA, Longhini ALF, Duarte ASS, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos P de M, Favaro P, Traina F, Saad STO. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion [Internet]. Stem Cells and Development. 2014 ; 23( 10): 1109-1120.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1089/scd.2013.0441
Vancouver
Roversi FM, Lopes MR, Machado Neto JA, Longhini ALF, Duarte ASS, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos P de M, Favaro P, Traina F, Saad STO. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion [Internet]. Stem Cells and Development. 2014 ; 23( 10): 1109-1120.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1089/scd.2013.0441
Trabalho de evento-resumo
FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation (2013)
Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Traina, Fabíola; Pereira, João Kleber Novais; Lorand-Metze, Irene; Costa, Fernando Ferreira; Saad, Sara Teresinha Ollala; Favaro, Patricia
Source: Abstracts, Program and Personal Scheduler. Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Subjects: DOENÇAS HEMATOLÓGICAS, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper60188.html. Acesso em: 18 nov. 2024.
APA
Lopes, M. R., Machado Neto, J. A., Traina, F., Pereira, J. K. N., Lorand-Metze, I., Costa, F. F., et al. (2013). FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper60188.html
NLM
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html
Vancouver
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html
Trabalho de evento-resumo
Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease (2013)
Colella, Marina Pereira; Paula, Erich Vinicius de; Conran, Nicola; Machado Neto, João Agostinho ; Quaino, Susan K. P.; Bizzacchi, Joyce Maria Annicchino; Costa, Fernando Ferreira; Saad, Sara Teresinha Ollala; Traina, Fabíola
Source: Abstracts, Program and Personal Scheduler. Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Subjects: HEMOGLOBINAS (ANOMALIAS), INFLAMAÇÃO, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLELLA, Marina Pereira et al. Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper59824.html. Acesso em: 18 nov. 2024.
APA
Colella, M. P., Paula, E. V. de, Conran, N., Machado Neto, J. A., Quaino, S. K. P., Bizzacchi, J. M. A., et al. (2013). Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper59824.html
NLM
Colella MP, Paula EV de, Conran N, Machado Neto JA, Quaino SKP, Bizzacchi JMA, Costa FF, Saad STO, Traina F. Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper59824.html
Vancouver
Colella MP, Paula EV de, Conran N, Machado Neto JA, Quaino SKP, Bizzacchi JMA, Costa FF, Saad STO, Traina F. Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper59824.html
Artigo de periodico
Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients (2013)
Souza, M. C; Rodrigues, C. A; Silva, M. R. R; Ribeiro, J.; Tognon, R.; Castro, Fabíola Attié de; Simoes, Belinda Pinto; Souto, E. X; Chauffaille, M. L
Source: Medical Oncology. Unidades: FCFRP, FMRP
Subjects: IDOSOS, DOENÇAS HEMATOLÓGICAS, PROTEÍNAS QUINASES, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, M. C et al. Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients. Medical Oncology, v. 30, n. 2, 2013Tradução . . Disponível em: https://doi.org/10.1007/s12032-013-0555-2. Acesso em: 18 nov. 2024.
APA
Souza, M. C., Rodrigues, C. A., Silva, M. R. R., Ribeiro, J., Tognon, R., Castro, F. A. de, et al. (2013). Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients. Medical Oncology, 30( 2). doi:10.1007/s12032-013-0555-2
NLM
Souza MC, Rodrigues CA, Silva MRR, Ribeiro J, Tognon R, Castro FA de, Simoes BP, Souto EX, Chauffaille ML. Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients [Internet]. Medical Oncology. 2013 ; 30( 2):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-013-0555-2
Vancouver
Souza MC, Rodrigues CA, Silva MRR, Ribeiro J, Tognon R, Castro FA de, Simoes BP, Souto EX, Chauffaille ML. Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients [Internet]. Medical Oncology. 2013 ; 30( 2):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-013-0555-2
Trabalho de evento-resumo
Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression (2013)
Roversi, Fernanda Marconi; Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Longhini, Ana Leda; Duarte, Adriana Silva Santos; Palodetto, Bruna; Corrocher, Flavia Adolfo; Campos, Paula de Melo; Baratti, Mariana O.; Pericole, Fernando V.; Favaro, Patricia; Traina, Fabíola; Saad, Sara Teresinha Ollala
Source: Abstracts, Program and Personal Scheduler. Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Subjects: HEMATOPOESE, DOENÇAS HEMATOLÓGICAS, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVERSI, Fernanda Marconi et al. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper57527.html. Acesso em: 18 nov. 2024.
APA
Roversi, F. M., Lopes, M. R., Machado Neto, J. A., Longhini, A. L., Duarte, A. S. S., Palodetto, B., et al. (2013). Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper57527.html
NLM
Roversi FM, Lopes MR, Machado Neto JA, Longhini AL, Duarte ASS, Palodetto B, Corrocher FA, Campos P de M, Baratti MO, Pericole FV, Favaro P, Traina F, Saad STO. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57527.html
Vancouver
Roversi FM, Lopes MR, Machado Neto JA, Longhini AL, Duarte ASS, Palodetto B, Corrocher FA, Campos P de M, Baratti MO, Pericole FV, Favaro P, Traina F, Saad STO. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57527.html
Artigo de periodico
MDR-1 and GST polymorphisms are involved in myelodysplasia progression (2013)
Palodetto, Bruna; Campos, Paula de Melo; Benites, Bruno Deltreggia; Chauffaille, Maria de Lourdes Lopes Ferrari; Velloso, Elvira Deolinda Rodrigues Pereira; Traina, Fabiola; Saad, Sara Teresinha Olalla
Source: Leukemia Research. Unidade: FMRP
Subjects: IDOSOS, DOENÇAS HEMATOLÓGICAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALODETTO, Bruna et al. MDR-1 and GST polymorphisms are involved in myelodysplasia progression. Leukemia Research, v. 37, n. 8, p. 970-973, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.04.024. Acesso em: 18 nov. 2024.
APA
Palodetto, B., Campos, P. de M., Benites, B. D., Chauffaille, M. de L. L. F., Velloso, E. D. R. P., Traina, F., & Saad, S. T. O. (2013). MDR-1 and GST polymorphisms are involved in myelodysplasia progression. Leukemia Research, 37( 8), 970-973. doi:10.1016/j.leukres.2013.04.024
NLM
Palodetto B, Campos P de M, Benites BD, Chauffaille M de LLF, Velloso EDRP, Traina F, Saad STO. MDR-1 and GST polymorphisms are involved in myelodysplasia progression [Internet]. Leukemia Research. 2013 ; 37( 8): 970-973.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2013.04.024
Vancouver
Palodetto B, Campos P de M, Benites BD, Chauffaille M de LLF, Velloso EDRP, Traina F, Saad STO. MDR-1 and GST polymorphisms are involved in myelodysplasia progression [Internet]. Leukemia Research. 2013 ; 37( 8): 970-973.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2013.04.024
Trabalho de evento-resumo
IRS2 associates with JAK2 and may be involved in cell proliferation pathways in chronic myeloproliferative neoplasms (2013)
Campos, Paula de Melo; Machado Neto, João Agostinho ; Duarte, Adriana Silva Santos; Mendonça, Rafaela; Lorand-Metze, Irene; Costa, Fernando Ferreira; Saad, Sara Teresinha Ollala; Traina, Fabíola
Source: Abstracts, Program and Personal Scheduler. Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Subjects: MUTAÇÃO GENÉTICA, NEOPLASIAS, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. IRS2 associates with JAK2 and may be involved in cell proliferation pathways in chronic myeloproliferative neoplasms. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper62742.html. Acesso em: 18 nov. 2024.
APA
Campos, P. de M., Machado Neto, J. A., Duarte, A. S. S., Mendonça, R., Lorand-Metze, I., Costa, F. F., et al. (2013). IRS2 associates with JAK2 and may be involved in cell proliferation pathways in chronic myeloproliferative neoplasms. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper62742.html
NLM
Campos P de M, Machado Neto JA, Duarte ASS, Mendonça R, Lorand-Metze I, Costa FF, Saad STO, Traina F. IRS2 associates with JAK2 and may be involved in cell proliferation pathways in chronic myeloproliferative neoplasms [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper62742.html
Vancouver
Campos P de M, Machado Neto JA, Duarte ASS, Mendonça R, Lorand-Metze I, Costa FF, Saad STO, Traina F. IRS2 associates with JAK2 and may be involved in cell proliferation pathways in chronic myeloproliferative neoplasms [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 18 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper62742.html
Artigo de periodico
IL10 inversely correlates with the percentage of CD8+ cells in MDS patients (2013)
Lopes, Matheus Rodrigues; Traina, Fabiola; Campos, Paula de Melo; Pereira, João Kleber Novais; Machado Neto, João Agostinho ; Machado, Helymar da Costa; Gilli, Simone Cristina Olenscki; Saad, Sara Teresinha Olalla; Favaro, Patricia
Source: Leukemia Research. Unidade: FMRP
Subjects: IDOSOS, DOENÇAS HEMATOLÓGICAS, REGULAÇÃO GÊNICA, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, v. 37, n. 5, p. 541-546, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.01.019. Acesso em: 18 nov. 2024.
APA
Lopes, M. R., Traina, F., Campos, P. de M., Pereira, J. K. N., Machado Neto, J. A., Machado, H. da C., et al. (2013). IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, 37( 5), 541-546. doi:10.1016/j.leukres.2013.01.019
NLM
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019
Vancouver
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration